Grant application rejected

If you have a disease that occurs more frequently, the chances are good that drugs already exist or are (want to) be developed, because from a pharmaceutical company’s point of view, the investment is “worthwhile”.
But people with so-called “rare” diseases also want to benefit from the medical-technical achievements. No human being is “rare”, everyone is unique and everyone has the right to medical care. Research institutions and pharmaceutical companies should think more globally and consider the findings of all research projects as profitable.